GPC3 and neoplasm: Furthermore, the subgroup analysis based on tumor mass across different cell lines (Figure 10) revealed significant efficacy in all subgroups except for the E0771-GPC3 cell line (WMD = 0.07, 95% CI: -0.08 to 0.22).